FI102190B1 - Menetelmä pesäkkeitä stimuloivan tekijä-1:n uusien muotojen valmistamiseksi ja siinä käytettäviä DNA-sekvenssejä, vektoreita, ilmentämisjärjestelmiä ja rekombinanttisoluja - Google Patents

Menetelmä pesäkkeitä stimuloivan tekijä-1:n uusien muotojen valmistamiseksi ja siinä käytettäviä DNA-sekvenssejä, vektoreita, ilmentämisjärjestelmiä ja rekombinanttisoluja

Info

Publication number
FI102190B1
FI102190B1 FI883056A FI883056A FI102190B1 FI 102190 B1 FI102190 B1 FI 102190B1 FI 883056 A FI883056 A FI 883056A FI 883056 A FI883056 A FI 883056A FI 102190 B1 FI102190 B1 FI 102190B1
Authority
FI
Finland
Prior art keywords
dna sequences
stimulating factor
colony stimulating
vectors
preparation
Prior art date
Application number
FI883056A
Other languages
English (en)
Swedish (sv)
Other versions
FI102190B (fi
FI883056A0 (fi
FI883056A (fi
Inventor
Kirston Edward Koths
Robert Forgan Halenbeck
Ernest Seigo Kawasaki
Martha Ballie Ladner
Mazie Yee Coyne
Arsdell Janelle Nobel Van
George Arthur Martin
Original Assignee
Cetus Oncology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Oncology Corp filed Critical Cetus Oncology Corp
Publication of FI883056A0 publication Critical patent/FI883056A0/fi
Publication of FI883056A publication Critical patent/FI883056A/fi
Application granted granted Critical
Publication of FI102190B publication Critical patent/FI102190B/fi
Publication of FI102190B1 publication Critical patent/FI102190B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Luminescent Compositions (AREA)
FI883056A 1986-10-24 1988-06-23 Menetelmä pesäkkeitä stimuloivan tekijä-1:n uusien muotojen valmistamiseksi ja siinä käytettäviä DNA-sekvenssejä, vektoreita, ilmentämisjärjestelmiä ja rekombinanttisoluja FI102190B1 (fi)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US92306786A 1986-10-24 1986-10-24
US92306786 1986-10-24
US3965487A 1987-04-16 1987-04-16
US3965787A 1987-04-16 1987-04-16
US3965787 1987-04-16
US3965487 1987-04-16
US8702679 1987-10-16
PCT/US1987/002679 WO1988003173A2 (en) 1986-10-24 1987-10-16 New forms of colony stimulating factor-1

Publications (4)

Publication Number Publication Date
FI883056A0 FI883056A0 (fi) 1988-06-23
FI883056A FI883056A (fi) 1988-06-23
FI102190B FI102190B (fi) 1998-10-30
FI102190B1 true FI102190B1 (fi) 1998-10-30

Family

ID=27365583

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883056A FI102190B1 (fi) 1986-10-24 1988-06-23 Menetelmä pesäkkeitä stimuloivan tekijä-1:n uusien muotojen valmistamiseksi ja siinä käytettäviä DNA-sekvenssejä, vektoreita, ilmentämisjärjestelmiä ja rekombinanttisoluja

Country Status (12)

Country Link
EP (1) EP0272779B1 (fi)
JP (1) JP2644794B2 (fi)
AT (1) ATE105869T1 (fi)
AU (2) AU8007087A (fi)
CA (1) CA1339032C (fi)
DE (1) DE3789859T2 (fi)
DK (1) DK174237B1 (fi)
ES (1) ES2052580T3 (fi)
FI (1) FI102190B1 (fi)
HU (1) HU215241B (fi)
NO (1) NO301775B1 (fi)
WO (1) WO1988003173A2 (fi)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422105A (en) * 1985-02-05 1995-06-06 Cetus Oncology Corporation Use of recombinant colony stimulating factor 1
US5556620A (en) * 1985-02-05 1996-09-17 Cetus Oncology Corporation Use of recombinant colony stimulating factor-1 to enhance wound healing
US5573930A (en) * 1985-02-05 1996-11-12 Cetus Oncology Corporation DNA encoding various forms of colony stimulating factor-1
US5104650A (en) * 1985-02-05 1992-04-14 Cetus Corporation Uses of recombinant colony stimulating factor-1
US6156300A (en) * 1985-02-05 2000-12-05 Chiron Corporation Point mutants of N∇2 CSF-1 and carboxy truncated fragments thereof
US5837229A (en) * 1985-02-05 1998-11-17 Chiron Corporation Uses of recombinant colony stimulating factor-1
US6146851A (en) * 1985-02-05 2000-11-14 Chiron Corporation DNA encoding NV2 (long form) and carboxy truncated fragments thereof
AU595864B2 (en) * 1986-03-14 1990-04-12 Otsuka Pharmaceutical Co., Ltd. Il-1 alpha derivatives and drugs
HU212277B (en) * 1986-05-06 1996-04-29 Genetics Inst Process for producing m-csf
JP2583770B2 (ja) * 1986-09-17 1997-02-19 大塚製薬株式会社 遺伝子
JP2583829B2 (ja) * 1986-09-17 1997-02-19 大塚製薬株式会社 ヒトｍ−ｃｓｆ
US5650297A (en) * 1986-09-17 1997-07-22 Otsuka Pharmaceutical Co., Ltd. DNA encoding human colony-stimulating factors
EP0276551B1 (en) * 1986-12-07 1992-03-18 Morinaga Milk Industry Co., Ltd. Colony-stimulating factor and method for preparation thereof
CA1339757C (en) * 1987-04-16 1998-03-17 Robert F. Halenbeck Production of purified biologically active, bacterially produced recombinant human csf-1
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
CA1317244C (en) * 1987-07-24 1993-05-04 Ernest Seigo Kawasaki Production of biologically active forms of csf using a baculovirus (acnpv)-insect cell expression system
DK54589A (da) * 1988-02-08 1989-08-09 Otsuka Pharma Co Ltd Humane kolonistmulerende faktorer
JPH0610137B2 (ja) * 1988-02-29 1994-02-09 新技術事業団 ヒト単球−マクロファージコロニー刺激因子を有効成分とする造血器疾患治療剤
US5171675A (en) * 1988-07-28 1992-12-15 Cerretti Douglas P Macrophage colony stimulating factor-γ
WO1990012877A1 (en) * 1989-04-19 1990-11-01 Cetus Corporation Multifunctional m-csf proteins and genes encoding therefor
EP0410751B1 (en) * 1989-07-27 1996-04-10 Denki Kagaku Kogyo Kabushiki Kaisha Gene encoding M-CSF and related recombinant systems thereof
EP0452505A4 (en) * 1989-11-07 1991-10-30 Otsuka Pharmaceutical Co., Ltd. M-csf derivative, expression vector of said derivative, product of transformation by said vector, and production of them
US5714140A (en) * 1989-12-13 1998-02-03 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting the production of bioactive IL-1 by administering M-CSF
DE4014750A1 (de) * 1990-05-08 1991-11-14 Boehringer Mannheim Gmbh Muteine des granulozyten-stimulierenden faktors (g-csf)
AU639091B2 (en) * 1991-04-24 1993-07-15 Otsuka Pharmaceutical Co., Ltd. M-csf derivatives, expression vectors for said derivatives, transformants carrying said vectors and production of these
EP0955365A3 (en) * 1992-06-09 2000-12-20 Chiron Corporation Crystallization of M-CSF
WO1994016075A2 (en) * 1993-01-13 1994-07-21 Genetics Institute, Inc. Process for producing m-csf 223
GB2355791B (en) 1999-10-28 2004-10-20 Molecular Light Tech Res Ltd Detection of mRNA expression using chemiluminescent labelled probes
KR100371264B1 (ko) * 2000-01-25 2003-02-05 양문식 무라인 그래뉼로사이트-매크로파지 콜로니 자극 인자를포함하는 재조합 벡터와 그것을 발현하는 재조합아스퍼질러스 나이거
PT3417701T (pt) 2009-10-06 2022-03-16 Univ Yale Ratinhos modificados geneticamente e enxerto
FI3375284T3 (fi) * 2011-02-15 2023-06-15 Regeneron Pharma Humanisoituja m-csf-hiiriä ja niiden käyttötapoja
KR20240045263A (ko) 2012-09-07 2024-04-05 예일 유니버시티 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법
RU2673156C2 (ru) 2012-11-05 2018-11-22 Ридженерон Фармасьютикалз, Инк. Генетически модифицированные не относящиеся к человеческому роду животные и способы их применения
CN113045639A (zh) 2014-05-19 2021-06-29 再生元制药公司 表达人epo的经遗传修饰的非人动物
SG11201708380WA (en) 2015-04-13 2017-11-29 Regeneron Pharma Humanized sirpa-il15 knockin mice and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU594045B2 (en) * 1985-02-05 1990-03-01 Chiron Corporation Recombinant colony stimulating factor-1
JP2583770B2 (ja) * 1986-09-17 1997-02-19 大塚製薬株式会社 遺伝子

Also Published As

Publication number Publication date
HUT47635A (en) 1989-03-28
FI102190B (fi) 1998-10-30
FI883056A0 (fi) 1988-06-23
WO1988003173A2 (en) 1988-05-05
JP2644794B2 (ja) 1997-08-25
ATE105869T1 (de) 1994-06-15
EP0272779B1 (en) 1994-05-18
NO882772D0 (no) 1988-06-22
NO882772L (no) 1988-08-22
AU646277B2 (en) 1994-02-17
EP0272779A2 (en) 1988-06-29
EP0272779A3 (en) 1988-08-03
WO1988003173A3 (en) 1988-07-28
DE3789859T2 (de) 1994-09-15
ES2052580T3 (es) 1994-07-16
DK350188D0 (da) 1988-06-24
AU8149491A (en) 1991-10-31
DE3789859D1 (de) 1994-06-23
DK174237B1 (da) 2002-10-07
DK350188A (da) 1988-08-19
FI883056A (fi) 1988-06-23
AU8007087A (en) 1988-04-28
NO301775B1 (no) 1997-12-08
CA1339032C (en) 1997-04-01
JPH01501283A (ja) 1989-05-11
HU215241B (hu) 1998-11-30

Similar Documents

Publication Publication Date Title
FI102190B1 (fi) Menetelmä pesäkkeitä stimuloivan tekijä-1:n uusien muotojen valmistamiseksi ja siinä käytettäviä DNA-sekvenssejä, vektoreita, ilmentämisjärjestelmiä ja rekombinanttisoluja
FI864016A (fi) Med rekombinant-dna-teknik erhaollen kolonistimulerande faktor-1.
NO164177C (no) Rekombinant dna-fremgangsmaate for fremstilling av et polypeptid med funksjon av human immun (gamma)-interferon.
DK161152C (da) Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
NO872988D0 (no) Pattedyr-interleukin-4.
SE8101005L (sv) Mikrobiologiskt framstelld polypeptid med samma aminosyrasekvens som hos humant interferon, dna och plasmider, som koderar for denna sekvens, mikroorganismer, som innehaller dessa genetiska informationer och forfaran...
DE68929134D1 (de) Endothelin-DNA und Verwendung davon
DE69333346T2 (de) Neuartiges p- selectin ligandenprotein
DK308586D0 (da) Dna-sekvens, der koder for et specifikt protein, rekombinantvektor, der omfatter sekvensen, og celler, der er transficerede til ekspression af proteinet
BG60238B1 (bg) Човешки тумор- некротизиращ фактор
EP0835661A3 (en) Human interferon-Beta2A for use as a medicament
AU6989687A (en) Preparation of factor XIIIa by gene manipulation
DE3880032D1 (de) Expressionsvektoren fuer die produktion von humanem gm-csf in saengerzellen.
FI871607A0 (fi) Menetelmä peptidien valmistamiseksi, menetelmässä käyttökelpoinen yhdistelmäplasmidi ja plasmidilla transformoituja myeloomasoluja
ES2039390T3 (es) Un procedimiento para producir un factor de diferenciacion de celulas b humanas.
ATE291629T1 (de) Expressionssystem für die sekretion von bioaktivem, menschlichem granulozyt-makrophagem koloniestimulierungsfaktor (gm-csf) und anderen heterologen proteinen aus streptomyces
ES8703928A1 (es) Un metodo para preparar la proteina factor de estimulacion de colonias (csf-1)recombinante
SU1380209A1 (ru) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК PUR 291-HAV 22, КОДИРУЮЩАЯ СИНТЕЗ ГИБРИДНОГО ПОЛИПЕПТИДА АНТИГЕННЫХ ДЕТЕРМИНАНТ ВИРУСА ГЕПАТИТА А С β -ГАЛАКТОЗИДАЗОЙ

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: CETUS ONCOLOGY CORPORATION